Alaunos Therapeutics (WEK0) Q2 2024 Earnings Report
DE:WEK0 Q2 2024 EPS Results
- Actual EPS
- -EUR 0.63
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 5.36
DE:WEK0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 3,576.439
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +0.00%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/08/2024
- Time
- TBA
- Conference Call
- Thursday, August 8, 2024
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:WEK0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 07, 2024 | 2024 (Q3) | ―-0.63 | -5.36 | 88.27% (+4.74) | |
| Aug 08, 2024 | 2024 (Q2) | ―-0.63 | -5.36 | 88.25% (+4.73) | |
| May 09, 2024 | 2024 (Q1) | ―-0.09 | -0.54 | 82.50% (+0.44) | |
| Mar 05, 2024 | 2023 (Q4) | -0.40-0.44 | -0.54 | 18.33% (+0.10) | |
| Nov 14, 2023 | 2023 (Q3) | -4.69-5.36 | -5.36 | 0.00% (+0.00) | |
| Aug 14, 2023 | 2023 (Q2) | -5.71-5.36 | -6.71 | 20.00% (+1.34) | |
| May 10, 2023 | 2023 (Q1) | -5.67-5.36 | -6.71 | 20.00% (+1.34) | |
| Mar 07, 2023 | 2022 (Q4) | -6.97-5.36 | -6.71 | 20.00% (+1.34) | |
| Nov 14, 2022 | 2022 (Q3) | -6.89-5.36 | -14.75 | 63.64% (+9.39) | |
| Aug 15, 2022 | 2022 (Q2) | -6.44-6.71 | -14.75 | 54.55% (+8.05) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
